Project Grant R01EY036466
Award Date
9/30/24
Completion Date
4/30/28
Dollars Obligated
$1.4M
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the human eye. The $543,037 award, effective September 1, 2024 through May 31, 2028, will fund investigations into the genetic and molecular mechanisms underlying corneal development and function. Key research objectives include identifying transcription factors and...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 - Vision Research) in the amount of $753,189 to Trustees of Boston University, doing business as Boston University Medical Campus, with a period of performance from August 1, 2024 to May 31, 2029. The grant will support research to identify novel therapeutic targets for corneal epithelial defects by revealing the differential roles of basal epithelial cells in the central cornea, limbus, and conjunctiva in corneal health and...
This Project Grant award of $422,199 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to explore a new therapeutic approach for treating meibomian gland dysfunction (MGD), a leading cause of dry eye disease. The research aims to investigate the use of estrogen receptor (ER) inhibitors, such as tamoxifen and fulvestrant, to suppress ER activity and increase androgen receptor (AR) function in the meibomian glands, with the goal of enhancing...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $246,000 to The Regents of the University of California, San Francisco to conduct research on serum components that support corneal health. The goal is to define the combinations of serum factors, such as growth factors, signaling lipids, and vitamins, that can restore healthy corneal function and treat diverse ocular surface disorders. The research aims to improve the clinical use of...
This Project Grant award from the National Eye Institute's Vision Research program (CFDA 93.867) provides $2,174,069.00 to The Trustees of the University of Pennsylvania to conduct research on developing novel mRNA-based treatments for Fuchs' Endothelial Corneal Dystrophy (FECD). The study aims to elucidate the regenerative potential of corneal endothelial cells and devise innovative therapeutic interventions to restore corneal transparency and vision in FECD patients. Key research activities...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), provides $432,191 to investigate the molecular mechanisms underlying cold storage-induced damage to the corneal endothelium. The research aims to elucidate how oxidative stress from cold storage disrupts the corneal endothelium's barrier and fluid pump functions, leading to delayed recovery of corneal transparency after transplantation. Specifically, the study will examine how...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), supports research to investigate the relationship between myofibroblasts and alloreactive T cells in corneal transplantation. The $540,213 award to The Schepens Eye Research Institute, Inc., effective August 1, 2025 through July 31, 2030, aims to: 1) define the mechanisms by which myofibroblasts regulate alloreactive effector T cell function, and 2) define the mechanisms by...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $588,731 to The University of Iowa to investigate the role of ferroptosis, a type of oxidative cell death, in the progression of Fuchs Endothelial Corneal Dystrophy (FECD). The key research objectives are to: 1) Define the interplay between FECD-associated corneal guttae and ferroptosis, 2) Determine how ultraviolet-A light exposure mediates ferroptosis in FECD, and 3) Develop drug therapies to...
The National Eye Institute (NEI) awarded a $586,258 Project Grant under the Vision Research program (CFDA 93.867) to Wayne State University to conduct research on the role of eosinophils in modulating the corneal response to Pseudomonas aeruginosa infection. The research, spanning from Jul 1, 2025 to Apr 30, 2029, aims to characterize the spatiotemporal distribution, phenotypic profiles, and proteomic changes of eosinophils during corneal inflammation and infection using mouse models. The...
This $148,568 Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), supports research at Emory University to investigate the role of scleral fibroblasts in refractive development and myopia. The primary objectives are to: 1) Identify characteristics of scleral fibroblasts in mouse eyes that undergo normal refractive development versus those exposed to myopic stimuli, and 2) Determine the role of retinoic acid signaling in driving...